| | 1 | Name: | Dr. Ruth Arnon | | | Institution: | The Weizmann Institute of Science | | | Year Elected: | 2009 | | | Class: | 2. Biological Sciences | | | Subdivision: | 209. Neurobiology | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1933 | | | | | | |
Prof. Arnon joined the Weizmann Institute of Science in 1960. Prior to her appointment as Vice-President, she served as Head of the Department of Chemical Immunology, and as Dean of the Faculty of Biology. From 1985 to 1994, she was the Director of the Institute's MacArthur Center for Molecular Biology of Tropical Diseases. Prof. Arnon has made significant contributions to the fields of vaccine development, cancer research and to the study of parasitic diseases. Along with Prof. Michael Sela and Dr. Dvora Teitelbaum she developed Copaxone,® a drug for the treatment of multiple sclerosis which was approved by the U.S. Food and Drug Administration, and is presently marketed in the USA, Canada the EU, Australia and many other countries worldwide. Prof. Arnon is a member of the Israel Academy of Sciences, and serves as its Vice-President since 2004. On the world scene, she is an elected member of the European Molecular Biology Organization (EMBO). She has served as President of the European Federation of Immunological Societies (EFIS), and as Secretary-General of the International Union of Immunological Societies (IUIS), as well as in the European Union Research Advisory Board (EURAB). Her awards include the Robert Koch Prize in Medical Sciences, Spain's Jiminez Diaz Memorial Prize, France's Legion of Honor, the Hadassah World Organization's Women of Distinction Award, the Wolf Prize for Medicine, the Rothschild Prize for Biology, and the Israel Prize, Honorary degree – Ben-Gurion University of the Negev, Israel, The AESKU Prize for Life Contribution to Autoimmunity by the 6th International Congress on Autoimmunity, “Yakir” Tel-Hai Academic College, Israel, Elected to the American Philosophical Society. Prof. Arnon is also the Scientific Advisor to the President of the State of Israel. Prof. Arnon is the incumbent of the Paul Ehrlich Chair in Immunochemistry. | |
| 2 | Name: | Dr. Carlos Chagas | | | Institution: | Univeridade Federal de Rio de Janeiro | | | Year Elected: | 1968 | | | Class: | 2. Biological Sciences | | | Subdivision: | 209. Neurobiology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1910 | | | Death Date: | February 16, 2000 | | | | |
| 3 | Name: | Prof. Francis H. C. Crick | | | Institution: | Salk Institute & University of California, San Diego | | | Year Elected: | 1972 | | | Class: | 2. Biological Sciences | | | Subdivision: | 209. Neurobiology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1916 | | | Death Date: | July 28, 2004 | | | | |
| 4 | Name: | Sir John C. Eccles | | | Institution: | State University of New York, Buffalo | | | Year Elected: | 1964 | | | Class: | 2. Biological Sciences | | | Subdivision: | 209. Neurobiology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1903 | | | Death Date: | 5/2/97 | | | | |
| 5 | Name: | Dr. Franz Huber | | | Institution: | Max Planck Institute | | | Year Elected: | 1986 | | | Class: | 2. Biological Sciences | | | Subdivision: | 209. Neurobiology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1925 | | | Death Date: | April 27, 2017 | | | | | | |
Franz Huber was a leader in the study of insect communication. His work provided direct evidence for the localization of the neural and motor system involved in sound production in cricket song and formed the basis of modern neuroethology of behavior of insects. He also made fundamental contributions to an understanding of the role of pattern generators in behavior. Dr. Huber held a number of academic posts, including assistant and associate professor at the University of Tübingen's Institute of Animal Physiology (1949-63) and professor of zoology and animal physiology (1962-73) and dean of the faculty of natural sciences (1967-68) at the University of Cologne. Later, he organized and directed the Max-Planck-Institut in Seewiesen, Germany, serving both as a scientific member and research director. After retiring from the Institut, he was named Professor Emeritus. Dr. Huber's many honors include the Karl Ritter von Frisch Medal (1980), the Polish Physiological Society's Napoleon Cybulski Medal (1983) four honorary doctor degrees (Cologne 1988, Toulouse 1991, Odense 1992 and Zurich 1993), and elections to seven academies, including election as a foreign member to the American Academy of Arts & Sciences. He was elected a member of the American Philosophical Society in 1986. | |
| 6 | Name: | Dr. Erling Norrby | | | Institution: | Royal Swedish Academy of Sciences & Karolinska Institute; J. Craig Venter Institute | | | Year Elected: | 2000 | | | Class: | 2. Biological Sciences | | | Subdivision: | 209. Neurobiology | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1937 | | | | | | |
Erling Norrby is Professor at the Karolinska Institute and Secretary General of The Royal Swedish Academy of Sciences. He received an M.D. in 1963, Ph.D. in 1964, and Docent of Medicine in 1964 from the Karolinska Institute, Stockholm. He served as chairman of the Department of Virology from 1972-1990 and Dean of Medical Faculty from 1990-97 at the Karolinska Institute. Erling Norrby has achieved a high level of accomplishment and recognition for academic research in viruses and diseases and as a leader in science and medicine. His laboratory career focused on viruses and immunopathogenesis, with particularly important contributions to the Paramyxoviruses (measles, atypical measles, SSPE) and to the retroviruses causing AIDS in man (HIV) and animals (SIV). He is the recipient of several awards, including the Career Award of the Swedish Cancer Society, 1966-72 and the Fernström Prize, 1981. He has served on the World Health Organization's Expert Advisory Committee since 1975. And served the Nobel Committee in various capacities, from 1975 to 1993. Dr. Norrby has been a member of the Swedish Royal Academy of Sciences since 1981 and the Academia Europea since 1998. He was elected to the American Philosophical Society in 2000. | |
| 7 | Name: | Dr. Michael Sela | | | Institution: | Weizmann Institute of Science | | | Year Elected: | 1995 | | | Class: | 2. Biological Sciences | | | Subdivision: | 209. Neurobiology | | | Residency: | International | | | Living? : |
Deceased
| | | Birth Date: | 1924 | | | Death Date: | May 27, 2022 | | | | | | |
One of the world's leading chemical immunologists, Michael Sela is the W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science. During his tenure at the Institute, which began in 1963, he has served as Dean of the Faculty of Biology (1970-73), as President (1975-85) and as Deputy Chair of the Board of Governors (1985-94). Considered a premier ambassador for Israeli science, Dr. Sela has most successfully applied his understanding of proteins and synthetic amino acid polymers to the manipulation of the immune system. He has also been responsible for the design and production of the specific immunogenic molecule "COP 1," which has positive actions in counteracting the autoimmune process in multiple sclerosis. Dr. Sela's scientific contributions have been recognized internationally by major honors and prizes, including the Warburg (1968), Landsteiner (1986) and UNESCO Albert Einstein (1995) Medals, the German Order of Merit and the French Legion d'Honeur. He is a member of the Max-Planck-Society, the Israel Academy of Sciences and Humanities the American Academy of Arts & Sciences and the National Academies of the U.S., France, Russia, Germany, Vatican, Romania, and Italy, and a recipient of nine honorary doctorates from the USA, Mexico, France and Israel. He received his Ph.D. from the Hebrew University in 1954. | |
| 8 | Name: | Sir John Skehel | | | Institution: | The Francis Crick Institute; Royal Society; National Institute for Medical Research (NIMR) | | | Year Elected: | 2020 | | | Class: | 2. Biological Sciences | | | Subdivision: | 209. Neurobiology | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1941 | | | | | | |
John Skehel
I graduated BSc at the University College of Wales, Aberystwyth in 1962, and PhD in biochemistry at Manchester University in 1966. I began research on viruses in Aberdeen University, and at Duke University, North Carolina, and in 1969 I returned to the National Institute for Medical Research in Mill Hill, London where I have spent all my research career. I work mainly on influenza viruses, how they infect cells, how they frequently change, and how we protect ourselves against them.
Between 1975 and 1994 I was Director of the WHO International Centre for reference and research on influenza viruses at Mill Hill. From 1987 until 2006, I was Director of the Institute and Head of Infections and Immunity, positions that allowed me to enjoy and support the Institute’s unique research environment. This was a great privilege and I was fortunate to be able to continue my research in the Division of Virology. Currently I am in the same laboratory at the newly formed Francis Crick Institute.
I am a Fellow of the University of Wales, of the Royal Society and of the Academy of Medical Sciences, a Member of the Academia Europaea, and an International Member of the American Philosophical Society and National Academy of Sciences of the USA. I was knighted in 1996. | |
| 9 | Name: | Dr. Rolf M. Zinkernagel | | | Institution: | Institute of Experimental Immunology, University of Zurich | | | Year Elected: | 2001 | | | Class: | 2. Biological Sciences | | | Subdivision: | 209. Neurobiology | | | Residency: | International | | | Living? : |
Living
| | | Birth Date: | 1944 | | | | | | |
Rolf Zinkernagel received an M.D. in 1968 from the University of Basel and a Ph.D. in 1975 from the Australian National University. He was a professor in the Department of Pathology at the Scripps Clinic and Research Foundation (1976-79) and a professor at the University Hospital in Zurich (1979-88). He has been a full professor and director of the Institute of Experimental Immunology at the University of Zurich since 1992. Rolf Zinkernagel elucidated the biologic significance of the major histocompatibility complex (MHC) restricted adaptive immune response. This kind of response provides protection from a panoply of viruses, bacteria, fungi and protozoa that have no or low cytotoxicity and, coincidentally, is the fundamental barrier to in-species tissue and organ transplantation (e.g. human to human organ and bone marrow transplantation). Dr. Zinkernagel was awarded the Lasker Award in 1995. In 1996 he was awarded the Nobel Prize in Medicine "for discoveries concerning the specificity of the cell mediated immune defense." He was elected as an international fellow of the Royal Society and an international member of the American Philosophical Society in 2001. | |
| |